PharmaEngineROCO:4162 -1.86%79 Dividend Yield % is 10.36% as of Jun. 27, 2026, which is 463% above its 10-year median of 1.84. GuruFocus rates ROCO:4162 with a GF Score™ of 79/100 and a GF Value™ of NT$114.87 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 151 Biotechnology companies, PharmaEngine ranks better than 98.01% on this metric.
As of today (2026-06-27), the Trailing Annual Dividend Yield of PharmaEngine is 10.36%.
Good Sign:
PharmaEngine Inc stock Dividend Yield % is close to 10-year high.
The historical rank and industry rank for PharmaEngine's Dividend Yield % or its related term are showing as below:
ROCO:4162'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.55 Med: 1.84 Max: 11.19
Current: 10.36
During the past 13 years, the highest Dividend Yield of PharmaEngine was 11.19%. The lowest was 0.55%. And the median was 1.84%.
ROCO:4162's Dividend Yield % is ranked better than 98.01% of 151
companies
in the Biotechnology industry
Industry Median: 1.53
vs ROCO:4162: 10.36
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of PharmaEngine Inc is 2.23, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of PharmaEngine was 3.45. The lowest was 0.12. And the median was 0.96.
During the past 12 months, PharmaEngine's average Dividends Per Share Growth Rate was 300.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 30.50% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 35.20% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 13.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of PharmaEngine was 58.70% per year. The lowest was -33.00% per year. And the median was 19.35% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for PharmaEngine's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4162 vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, PharmaEngine's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaEngine Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PharmaEngine's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where PharmaEngine's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
PharmaEngine Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 6.000000
2025-08-13
2025-08-14
2025-08-29
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
PharmaEngine's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
6
/
57.90
=
10.36 %
Current Share Price is NT$57.90. PharmaEngine's Dividends per Share for the trailing twelve months (TTM) ended in Today is NT$6.
PharmaEngine's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
6
/
57.90
=
10.36 %
Current Share Price is NT$57.90. PharmaEngine's Dividends per Share for the forward twelve months is calculated as NT$6 * 1 = NT$6.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmaEngine (ROCO:4162) has a Dividend Yield % of 10.36% as of Jun. 27, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on PharmaEngine and its competitors. This is 463% above median its historical median of 1.84. Over the past decade, PharmaEngine's Dividend Yield % has ranged from 0.55 to 11.19. According to the industry distribution chart, PharmaEngine ranks #3 out of 151 companies in the Biotechnology industry, placing it in the top 2%.
Is PharmaEngine's Dividend Yield % too high?
PharmaEngine's current Dividend Yield % of 10.36% is 463% above median its 10-year median of 1.84. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 11.19. The Biotechnology industry median Dividend Yield % is 1.53. PharmaEngine's value of 10.36% is 577.1% above this industry median. Based on the distribution chart, PharmaEngine ranks #3 out of 151 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PharmaEngine has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PharmaEngine's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PharmaEngine ranks #3 out of 151 companies for Dividend Yield %. This places PharmaEngine in the top 2% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.53. PharmaEngine's value of 10.36% is 577.1% above this benchmark. Historically, PharmaEngine's own Dividend Yield % has ranged from 0.55 to 11.19 over the past decade. While the company's 10-year median is 1.84 vs. the industry median of 1.53, PharmaEngine has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.53, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaEngine's current Dividend Yield % of 10.36% is 577.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on PharmaEngine and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaEngine's current Dividend Yield % is 10.36%, which is 463% above median its own 10-year median of 1.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEngine stock overvalued right now?
Based on GuruFocus' analysis, PharmaEngine (ROCO:4162) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$114.87, compared to a current price of NT$57.90 — trading 49.6% below its estimated fair value. The current Dividend Yield % is 10.36%, which is 463% above median its 10-year median of 1.84 and 577.1% above the Biotechnology industry median of 1.53. PharmaEngine's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For PharmaEngine (ROCO:4162), the current Dividend Yield % is 10.36% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PharmaEngine (ROCO:4162) Overvalued in 2026?
Based on GuruFocus' analysis, PharmaEngine stock appears to be undervalued.
The current stock price of NT$57.90 is trading 49.6% below its estimated GF Value™ of NT$114.87.
GuruFocus considers PharmaEngine to be Significantly Undervalued.
Key valuation signals for ROCO:4162:
Dividend Yield %: 10.36% (463% above median its 10-year median of 1.84)
GF Value™: NT$114.87 vs. price of NT$57.90 (49.6% below fair value)
Industry Position: 577.1% above the Biotechnology median (#3 of 151)
No single metric tells the full story. See the ROCO:4162 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its key products and pipeline projects include ONIVYDE, a treatment for metastatic pancreatic cancer approved in multiple markets, as well as oncology candidates such as PEP07 and PEP08. It generates revenue from the sales of goods.
79GF Score
Get the complete analysis for ROCO:4162
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4162 has been successfully added to your 
